Drug intelligence / Profile preview

autologous cultured dermal cells

Development stage: Unknown
Lead developer: Aderans Research Institute
Modality: Cell Therapies
Administration: Injection

Overview

Autologous cultured dermal cells are a cell therapy developed by Aderans Research Institute. This biological product involves taking a piece of occipital scalp from a subject, expanding the dermal cells from this tissue ex vivo in culture, harvesting them, and then injecting these cells into the balding area of the original subject's scalp. The therapy is designed to induce hair growth in individuals experiencing hair loss. It is being evaluated for its efficacy in male and female subjects with hair loss, sometimes in combination with topical minoxidil.

Brand names: Ji Gami(TM) DO

Beyond the preview

Go deeper on autologous cultured dermal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous cultured dermal cells.

Explore the full profile